SO
68
2
BF.B
48
-3
AMAT
66
2
WBA
34
7
VNO
55
3
ADI
65
3
NEE
39
-5
A
40
4
EXC
40
5
MPC
44
2
ESS
79
2
TAP
34
2
RCL
64
2
GWW
48
4
GOOG
73
-8
PX
46
4
HD
55
5
MA
64
4
PHM
63
-2
HCP
60
-2
SO
68
2
BF.B
48
-3
AMAT
66
2
WBA
34
7
VNO
55
3
ADI
65
3
NEE
39
-5
A
40
4
EXC
40
5
MPC
44
2
ESS
79
2
TAP
34
2
RCL
64
2
GWW
48
4
GOOG
73
-8
PX
46
4
HD
55
5
MA
64
4
PHM
63
-2
HCP
60
-2
Financhill
Back

Boston Properties Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
46

BXP
Boston Properties

Last Price:
61.39
Seasonality Move:
2.12%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
38.01
Seasonality Move:
3.65%
Sell
46
Boston Properties (BXP) is a Sell

Is Boston Properties a Buy, Sell or Hold?

  • The current Boston Properties [BXP] share price is $62.05. The Score for BXP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • BXP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BXP Stock Price Chart

What is Boston Properties's stock price today?

  • The Boston Properties share price today is $62.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BXP is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

BXP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 56.11 Buy
Chaikin Money Flow: 159848 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (58.82 - 62.66) Buy
Bollinger Bands (100): (59.99 - 65.37) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 37.74 Sell
Chaikin Money Flow: -836354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.26 - 42.36) Sell
Bollinger Bands (100): (41.26 - 48.86) Sell

BXP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 60.39 Buy
20-day SMA: 60.05 Buy
50-day SMA: 60.9 Buy
200-day SMA: 62.25 Sell
8-day EMA: 60.89 Buy
20-day EMA: 60.59 Buy
50-day EMA: 61.18 Buy
200-day EMA: 62.67 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.11 Sell
20-day SMA: 40.61 Sell
50-day SMA: 42.43 Sell
200-day SMA: 42.45 Sell
8-day EMA: 40.32 Sell
20-day EMA: 40.92 Sell
50-day EMA: 42.29 Sell
200-day EMA: 43.55 Sell

Boston Properties Earnings Growth & BXP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.45 per share, and an increase next year of $0.16 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Boston Properties Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):